Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Surfactant in COVID-19 Patients
NCT04847375Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2021
- Primary completion
- Jul 2021
01
Overview
Randomised, open-label trial in coronavirus disease 2019 (COVID-19) and respiratory distress syndrome (RDS) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Rate of Tracheal Intubation at 1 year, Rate of ICU Admission at 1 year and 1 more. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT04847375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04847375.